• 1
    Whitaker D, Papadimitriou JM, Walters MN. The mesothelium and its reactions: A review. Crit. Rev. Toxicol. 1982; 10: 81144.
  • 2
    Minot CS. A sketch of comparative embyology. Am. Nat. 1880; 14: 87180.
  • 3
    Minot CS. The mesoderm and the coelom of vertebrates. Am. Nat. 1890; 24: 87798.
  • 4
    Hesseldahl H, Larsen JF. Ultrastructure of human yolk sac: Endoderm, mesenchyme, tubules and mesothelium. Am. J. Anat. 1969; 126: 31535.
  • 5
    Tiedemann K. On the yolk sac of the cat. Endoderm and mesothelium. Cell Tissue Res. 1976; 173: 10927.
  • 6
    Moore KL(ed.). The Developing Human, 3rd edn. WB Saunders, Philadelphia, 1982.
  • 7
    Odor DL. Observations of the rat mesothelium with the electron and phase microscopes. Am. J. Anat. 1954; 95: 43356.
  • 8
    Fukata H. Electron microscopic study on normal rat peritoneal mesothelium and its changes in absorption of particulate iron dextran complex. Acta Pathol. Jpn. 1963; 13: 30925.
  • 9
    Kluge T, Hovig T. The ultrastructure of human and rat pericardium. I. Parietal and visceral mesothelium. Acta Pathol. Microbiol. Scand. 1967; 71: 52946.
  • 10
    Kluge T, Hovig T. The ultrastructure of human and rat pericardium. II. Intercellular spaces and junctions. Acta Pathol. Microbiol. Scand. 1967; 71: 54763.
  • 11
    Andrews PM, Porter KR. The ultrastructural morphology and possible functional significance of mesothelial microvilli. Anat. Rec. 1973; 177: 40926.
  • 12
    Bettendorf U. Lymph flow mechanism of the subperitoneal diaphragmatic lymphatics. Lymphology 1978; 11: 11116.
  • 13
    Mironov VA, Gusev SA, Baradi AF. Mesothelial stomata overlying omental milky spots: Scanning electron microscopic study. Cell Tissue Res. 1979; 201: 32730.
  • 14
    Baradi AF, Rao SN. A scanning electron microscope study of mouse peritoneal mesothelium. Tissue Cell 1976; 8: 15962.
  • 15
    Madison LD, Bergstrom-Porter B, Torres AR, Shelton E. Regulation of surface topography of mouse peritoneal cells. Formation of microvilli and vesiculated pits on omental mesothelial cells by serum and other proteins. J. Cell Biol. 1979; 82: 78397.
  • 16
    Suzuki Y, Kannerstein M, Churg J. Electron microscopy of normal, hyperplastic and neoplastic mesothelium. In: Bogovski P, Gilson JC, Timbrell V, Wagner JC (eds). Biological Effects of Asbestos. IARC Science Publishing, Lyon, 1973; 749.
  • 17
    Baradi AF, Hope J. Observations on ultrastructure of rabbit mesothelium. Exp. Cell Res. 1964; 34: 3344.
  • 18
    Wang NS. The regional difference of pleural mesothelial cells in rabbits. Am. Rev. Respir. Dis. 1974; 110: 623 33.
  • 19
    Tsilibary EC, Wissig SL. Absorption from the peritoneal cavity: SEM study of the mesothelium covering the peritoneal surface of the muscular portion of the diaphragm. Am. J. Anat. 1977; 149: 12733.
  • 20
    Tyler WS, Gillespie JR, Nowell JA. Modern functional morphology of the equine lung. Equine Vet. J. 1971; 3: 8494.
  • 21
    Salazar H, Kanbour A, Burgess F. Ultrastructure and observations on the histogenesis of mesotheliomas, ‘adenomatoid tumors’, of the female genital tract. Cancer 1972; 29: 14152.
  • 22
    Ishihara T, Ferrans VJ, Jones M, Boyce SW, Kawanami O, Roberts WC. Histologic and ultrastructural features of normal human parietal pericardium. Am. J. Cardiol. 1980; 46: 74453.
  • 23
    Gaudio E, Rendina EA, Pannarale L, Ricci C, Marinozzi G. Surface morphology of the human pleura. A scanning electron microscopic study. Chest 1988; 93: 149 53.
  • 24
    Raftery AT. An enzyme histochemical study of mesothelial cells in rodents. J. Anat. 1973; 115: 36573.
  • 25
    Whitaker D, Papadimitriou JM, Walters MN. The mesothelium: A histochemical study of resting mesothelial cells. J. Pathol. 1980; 132: 27384.
  • 26
    Bloom W, Fawcett DW(eds). A Textbook of Histology. WB Saunders, Philadelphia, 1975.
  • 27
    Albertine KH, Wiener-Kronish JP, Roos PJ, Staub NC. Structure, blood supply, and lymphatic vessels of the sheep's visceral pleura. Am. J. Anat. 1982; 165: 27794.
  • 28
    Michailova K, Wassilev W, Wedel T. Scanning and transmission electron microscopic study of visceral and parietal peritoneal regions in the rat. Anat. Anz. 1999; 181: 25360.
  • 29
    Whitaker D, Papadimitriou J. Mesothelial healing: Morphological and kinetic investigations. J. Pathol. 1985; 145: 15975.
  • 30
    Fotev Z, Whitaker D, Papadimitriou JM. Role of macrophages in mesothelial healing. J. Pathol. 1987; 151: 20919.
  • 31
    Mutsaers SE, Whitaker D, Papadimitriou JM. Stimulation of mesothelial cell proliferation by exudate macrophages enhances serosal wound healing in a murine model. Am. J. Pathol. 2001; 160: 68192.
  • 32
    Baradi AF, Campbell Jr WG. Exudative peritonitis induced in mice by bovine serum albumin. Arch. Pathol. 1974; 97: 212.
  • 33
    Lindic J, Psenicnik M, Bren A, Gucek A, Ferluga D, Kveder R. The morphology of parietal peritoneum: A scanning electron micrograph study. Adv. Perit. Dial. 1993; 9: 368.
  • 34
    Mutsaers SE, Whitaker D, Papadimitriou JM. Changes in the concentration of microvilli on the free surface of healing mesothelium are associated with alterations in surface membrane charge. J. Pathol. 1996; 180: 3339.DOI: 10.1002/(sici)1096-9896(199611)180:3<333::aid-path659>;2-y
  • 35
    Gotloib L, Shostack A, Jaichenko J. Ruthenium-red-stained anionic charges of rat and mice mesothelial cells and basal lamina: The peritoneum is a negatively charged dialyzing membrane. Nephron 1988; 48: 65 70.
  • 36
    Fedorko ME, Hirsch JG. Studies on transport of macromolecules and small particles across mesothelial cells of the mouse omentum. I. Morphologic aspects. Exp. Cell Res. 1971; 69: 11327.
  • 37
    Whitaker D. The mesothelium of the rat and its response to injury. PhD Thesis, University of Western Australia, Perth. 1984.
  • 38
    Cotran RS, Karnovsky MJ. Ultrastructural studies on the permeability of the mesothelium to horseradish peroxidase. J. Cell Biol. 1968; 37: 12337.
  • 39
    Leak LV, Rahil K. Permeability of the diaphragmatic mesothelium: The ultrastructural basis for ‘stomata’. Am. J. Anat. 1978; 151: 55793.
  • 40
    Pelin K, Hirvonen A, Linnainmaa K. Expression of cell adhesion molecules and connexins in gap junctional intercellular communication deficient human mesothelioma tumour cell lines and communication competent primary mesothelial cells. Carcinogenesis 1994; 15: 26735.
  • 41
    Citi S, Cordenonsi M. Tight junction proteins. Biochim. Biophys. Acta 1998; 1448: 111.
  • 42
    Yap AS, Brieher WM, Gumbiner BM. Molecular and functional analysis of cadherin-based adherens junctions. Annu. Rev. Cell Dev. Biol. 1997; 13: 119 46.
  • 43
    Wan H, Winton HL, Soeller C et al. Quantitative structural and biochemical analyses of tight junction dynamics following exposure of epithelial cells to house dust mite allergen Der p 1. Clin. Exp. Allergy 2000; 30: 68598.DOI: 10.1046/j.1365-2222.2000.00820.x
  • 44
    Wan H, Winton HL, Soeller C et al. The transmembrane protein occludin of epithelial tight junctions is a functional target for serine peptidases from faecal pellets of Dermatophagoides pteronyssinus. Clin. Exp. Allergy 2001; 31: 27994.
  • 45
    Simsir A, Fetsch P, Mehta D, Zakowski M, Abati A. E-Cadherin, N-cadherin, and calretinin in pleural effusions: The good, the bad, the worthless. Diagn. Cytopathol. 1999; 20: 12530.DOI: 10.1002/(sici)1097-0339(199903)20:3<125::aid-dc3>;2-v
  • 46
    Foley-Comer AJ, Herrick SE, Al-Mishlab T, Prele CM, Laurent GJ, Mutsaers SE. Evidence for incorporation of free-floating mesothelial cells as a mechanism of serosal healing. J. Cell Sci. 2001; 115: 13839.
  • 47
    Von Recklinghausen FV. Zur fettresorption. Arch. Pathol. Anat. 1863; 24: 172208.
  • 48
    Wang NS. The preformed stomas connecting the pleural cavity and the lymphatics in the parietal pleura. Am. Rev. Respir. Dis. 1975; 111: 1220.
  • 49
    Leak LV. Interaction of mesothelium to intraperitoneal stimulation. I. Aggregation of peritoneal cells. Lab. Invest. 1983; 48: 47991.
  • 50
    Moalli PA, MacDonald JL, Goodglick LA, Kane AB. Acute injury and regeneration of the mesothelium in response to asbestos fibers. Am. J. Pathol. 1987; 128: 42645.
  • 51
    Shaw RJ, Benedict SH, Clark RA, King Jr TE. Pathogenesis of pulmonary fibrosis in interstitial lung disease. Alveolar macrophage PDGF (B) gene activation and up-regulation by interferon gamma. Am. Rev. Respir. Dis. 1991; 143: 16773.
  • 52
    Fukuo Y, Shinohara H, Matsuda T. The distribution of lymphatic stomata in the diaphragm of the golden hamster. J. Anat. 1990; 169: 1321.
  • 53
    Negrini D, Mukenge S, Del Fabbro M, Gonano C, Miserocchi G. Distribution of diaphragmatic lymphatic stomata. J. Appl. Physiol. 1991; 70: 15449.
  • 54
    Ohtani Y, Ohtani O, Nakatani T. Microanatomy of the rat diaphragm with special reference to the lymphatics and mesothelial stomata. Ital. J. Anat. Embryol. 1995; 100: 14353.
  • 55
    Li J. Ultrastructural study on the pleural stomata in human. Funct. Dev. Morph. 1993; 3: 27780.
  • 56
    Miura T, Shimada T, Tanaka K, Chujo M, Uchida Y. Lymphatic drainage of carbon particles injected into the pleural cavity of the monkey, as studied by video-assisted thoracoscopy and electron microscopy. J. Thorac. Cardiovasc. Surg. 2000; 120: 437 47.
  • 57
    Shao XJ, Ohtani O, Saitoh M, Ohtani Y. Development of diaphragmatic lymphatics: The process of their direct connection to the peritoneal cavity. Arch. Histol. Cytol. 1998; 61: 13749.
  • 58
    Nakatani T, Ohtani O, Tanaka S. Lymphatic stomata in the murine diaphragmatic peritoneum: The timing of their appearance and a map of their distribution. Anat. Rec. 1996; 244: 52939.DOI: 10.1002/(sici)1097-0185(199604)244:4<529::aid-ar11>;2-r
  • 59
    Ohtani Y, Ohtani O. Obliteration of the lymphatic trunks draining diaphragmatic lymph causes peritoneal fluid to enter the pleural cavity. Arch. Histol. Cytol. 1997; 60: 50310.
  • 60
    Shumko JZ, Feinberg RN, Shalvoy RM, DeFouw DO. Responses of rat pleural mesothelia to increased intrathoracic pressure. Exp. Lung Res. 1993; 19: 283 97.
  • 61
    Cotran RS, Nicca C. The intercellular localization of cations in mesothelium. A light and electron microscopic study. Lab. Invest. 1968; 18: 40715.
  • 62
    Whitaker D, Papadimitriou JM, Walters MN. The mesothelium. A cytochemical study of ‘activated’ mesothelial cells. J. Pathol. 1982; 136: 16979.
  • 63
    Agostoni E, Zocchi L. Mechanical coupling and liquid exchanges in the pleural space. Clin. Chest Med. 1998; 19: 24160.
  • 64
    Telvi L, Jaubert F, Eyquem A, Andreux JP, Labrousse F, Chretien J. Study of immunoglobulins in pleura and pleural effusions. Thorax 1979; 34: 38992.
  • 65
    Payne DK, Kinasewitz GT, Gonzalez E. Comparative permeability of canine visceral and parietal pleura. J. Appl. Physiol. 1988; 65: 255864.
  • 66
    Ramsey SJ, Tweeddale DN, Bryant LR, Braunstein H. Cytologic features of pericardial mesothelium. Acta Cytol. 1970; 14: 28390.
  • 67
    Raftery AT. Regeneration of parietal and visceral peritoneum. A light microscopical study. Br. J. Surg. 1973; 60: 2939.
  • 68
    Raftery AT. Regeneration of parietal and visceral peritoneum: An enzyme histochemical study. J. Anat. 1976; 121: 58997.
  • 69
    Marsan C, Cayphas J. The aid of some histochemical stains in the identification of mesothelial cells. Preliminary results. Acta Cytol. 1974; 18: 2528.
  • 70
    Efrati P, Nir E. Morphological and cytochemical investigation of human mesothelial cells from pleural and peritoneal effusions: A light and electron microscopy study. Isr. J. Med. Sci. 1976; 12: 66273.
  • 71
    Clausen PP, Hojgaard K, Thommesen N. The diagnostic value of cytochemical staining for non-specific esterase in the search for cancer cells in effusions. Acta Pathol. Microbiol. Scand. A 1979; 87A: 34752.
  • 72
    Whitaker D, Papadimitriou JM, Walters MN. The mesothelium: Techniques for investigating the origin, nature and behaviour of mesothelial cells. J. Pathol. 1980; 132: 26371.
  • 73
    Roth J. Ultrahistochemical demonstration of saccharide components of complex carbohydrates at the alveolar cell surface and at the mesothelial cell surface of the pleura visceralis of mice by means of concanavalin A. Exp. Pathol. 1973; 8: 15767.
  • 74
    Arai H, Endo M, Sasai Y et al. Histochemical demonstration of hyaluronic acid in a case of pleural mesothelioma. Am. Rev. Respir. Dis. 1975; 111: 699702.
  • 75
    Satoh K, Arai H, Nagai H et al. Acid glycosaminoglycans in experimental pleural effusions. Lung 1987; 165: 191 9.
  • 76
    Wang PM, Lai-Fook SJ. Effects of ventilation on hyaluronan and protein concentration in pleural liquid of anesthetized and conscious rabbits. Lung 1998; 176: 30924.
  • 77
    Castor CW, Naylor B. Characteristics of normal and malignant human mesothelial cells studied in vitro. Lab. Invest. 1969; 20: 43743.
  • 78
    Honda A, Ohashi Y, Mori Y. Hyaluronic acid in rabbit pericardial fluid and its production by pericardium. FEBS Lett. 1986; 203: 2738.
  • 79
    Ohashi Y, Honda A, Iwai T, Mori Y. Stimulatory effect of vanadate on hyaluronic acid synthesis in mesothelial cells from rabbit pericardium. Biochem. Int. 1988; 16: 293302.
  • 80
    Breborowicz A, Wisniewska J, Polubinska A, Wieczorowska-Tobis K, Martis L, Oreopoulos DG. Role of peritoneal mesothelial cells and fibroblasts in the synthesis of hyaluronan during peritoneal dialysis. Perit. Dial. Int. 1998; 18: 3826.
  • 81
    Yung S, Thomas GJ, Davies M. Induction of hyaluronan metabolism after mechanical injury of human peritoneal mesothelial cells in vitro. Kidney Int. 2000; 58: 195362.
  • 82
    Baumann MH, Strange C, Sahn SA, Kinasewitz GT. Pleural macrophages differentially alter pleural mesothelial cell glycosaminoglycan production. Exp. Lung Res. 1996; 22: 10111.
  • 83
    Heldin P, Pertoft H. Synthesis and assembly of the hyaluronan-containing coats around normal human mesothelial cells. Exp. Cell Res. 1993; 208: 4229.DOI: 10.1006/excr.1993.1264
  • 84
    Basbug M, Aygen E, Tayyar M, Kaya E, Narin F, Oktem O. Hyaluronic acid plus heparin for improved efficacy in prevention of adhesion formation in rat uterine horn model. Eur. J. Obstet. Gynecol. Reprod. Biol. 1998; 78: 10912.
  • 85
    Kramer K, Senninger N, Herbst H, Probst W. Effective prevention of adhesions with hyaluronate. Arch. Surg. 2001; 137: 27882.
  • 86
    Casey RC, Skubitz AP. CD44 and beta1 integrins mediate ovarian carcinoma cell migration toward extracellular matrix proteins. Clin. Exp. Metastasis 2000; 18: 6775.
  • 87
    Jones LM, Gardner MJ, Catterall JB, Turner GA. Hyaluronic acid secreted by mesothelial cells: A natural barrier to ovarian cancer cell adhesion. Clin. Exp. Metastasis 1995; 13: 37380.
  • 88
    Dobbie JW, Lloyd JK. Mesothelium secretes lamellar bodies in a similar manner to type II pneumocyte secretion of surfactant. Perit. Dial. Int. 1989; 9: 21519.
  • 89
    Dobbie JW, Pavlina T, Lloyd J, Johnson RC. Phosphatidylcholine synthesis by peritoneal mesothelium: Its implications for peritoneal dialysis. Am. J. Kidney Dis. 1988; 12: 316.
  • 90
    Beavis J, Harwood JL, Coles GA, Williams JD. Synthesis of phospholipids by human peritoneal mesothelial cells. Perit. Dial. Int. 1994; 14: 34855.
  • 91
    Dobbie JW. Surfactant protein A and lamellar bodies. A homologous secretory function of peritoneum, synovium, and lung. Perit. Dial. Int. 1996; 16: 57481.
  • 92
    Antony VB, Godbey SW, Kunkel SL et al. Recruitment of inflammatory cells to the pleural space. Chemotactic cytokines, IL-8, and monocyte chemotactic peptide-1 in human pleural fluids. J. Immunol. 1993; 151: 721623.
  • 93
    Boylan AM, Ruegg C, Kim KJ et al. Evidence of a role for mesothelial cell-derived interleukin 8 in the pathogenesis of asbestos-induced pleurisy in rabbits. J. Clin. Invest. 1992; 89: 125767.
  • 94
    Antony VB, Hott JW, Kunkel SL, Godbey SW, Burdick MD, Strieter RM. Pleural mesothelial cell expression of C-C (monocyte chemotactic peptide) and C-X-C (interleukin 8) chemokines. Am. J. Respir. Cell Mol. Biol. 1995; 12: 5818.
  • 95
    Visser CE, Steenbergen JJ, Betjes MG et al. Interleukin-8 production by human mesothelial cells after direct stimulation with staphylococci. Infect. Immun. 1995; 63: 42069.
  • 96
    Visser CE, Brouwer-Steenbergen JJ, Schadee-Eestermans IL, Meijer S, Krediet RT, Beelen RH. Ingestion of Staphylococcus aureus, Staphylococcus epidermidis, and Escherichia coli by human peritoneal mesothelial cells. Infect. Immun. 1996; 64: 34258.
  • 97
    Betjes MG, Tuk CW, Struijk DG et al. Interleukin-8 production by human peritoneal mesothelial cells in response to tumor necrosis factor-alpha, interleukin-1, and medium conditioned by macrophages cocultured with Staphylococcus epidermidis. J. Infect. Dis. 1993; 168: 120210.
  • 98
    Visser CE, Tekstra J, Brouwer-Steenbergen JJ et al. Chemokines produced by mesothelial cells: huGRO-alpha, IP-10, MCP-1 and RANTES. Clin. Exp. Immunol. 1998; 112: 2705.
  • 99
    Li FK, Davenport A, Robson RL et al. Leukocyte migration across human peritoneal mesothelial cells is dependent on directed chemokine secretion and ICAM-1 expression. Kidney Int. 1998; 54: 217083.
  • 100
    Nasreen N, Mohammed KA, Hardwick J et al. Polar production of interleukin-8 by mesothelial cells promotes the transmesothelial migration of neutrophils: Role of intercellular adhesion molecule-1. J. Infect. Dis. 2001; 183: 163845.
  • 101
    Haslinger B, Mandl-Weber S, Sellmayer A, Sitter T. Hyaluronan fragments induce the synthesis of MCP-1 and IL-8 in cultured human peritoneal mesothelial cells. Cell Tissue Res. 2001; 305: 7986.
  • 102
    Witowski J, Pawlaczyk K, Breborowicz A et al. IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO alpha chemokine from mesothelial cells. J. Immunol. 2000; 165: 581421.
  • 103
    Tanaka S, Choe N, Iwagaki A, Hemenway DR, Kagan E. Asbestos exposure induces MCP-1 secretion by pleural mesothelial cells. Exp. Lung Res. 2000; 26: 24155.
  • 104
    Nasreen N, Hartman DL, Mohammed KA, Antony VB. Talc-induced expression of C-C and C-X-C chemokines and intercellular adhesion molecule-1 in mesothelial cells. Am. J. Respir. Crit. Care Med. 1998; 158: 9718.
  • 105
    Coulomb-L’Hermin A, Amara A, Schiff C et al. Stromal cell-derived factor 1 (SDF-1) and antenatal human B cell lymphopoiesis: Expression of SDF-1 by mesothelial cells and biliary ductal plate epithelial cells. Proc. Natl Acad. Sci. USA 1999; 96: 858590.
  • 106
    Foussat A, Balabanian K, Amara A et al. Production of stromal cell-derived factor 1 by mesothelial cells and effects of this chemokine on peritoneal B lymphocytes. Eur. J. Immunol. 2001; 31: 3509.DOI: 10.1002/1521-4141(200102)31:2<350::aid-immu350>;2-s
  • 107
    Balabanian K, Foussat A, Bouchet-Delbos L et al. Interleukin-10 modulates the sensitivity of peritoneal B lymphocytes to chemokines with opposite effects on stromal cell-derived factor-1 and B-lymphocyte chemoattractant. Blood 2001; 99: 42736.
  • 108
    Katayama H, Yokoyama A, Kohno N et al. Production of eosinophilic chemokines by normal pleural mesothelial cells. Am. J. Respir. Cell Mol. Biol. 2001; 26: 398403.
  • 109
    Martinez-Garcia MA, Cases-Viedma E, Cordero-Rodriguez PJ et al. Diagnostic utility of eosinophils in the pleural fluid. Eur. Respir. J. 2000; 15: 1669.DOI: 10.1034/j.1399-3003.2000.15a30.x
  • 110
    Georas SN, Beck LA, Stellato C. What is eotaxin doing in the pleura? Insights into innate immunity from pleural mesothelial cells. Am. J. Respir. Cell Mol. Biol. 2001; 26: 3847.
  • 111
    Demetri GD, Zenzie BW, Rheinwald JG, Griffin JD. Expression of colony-stimulating factor genes by normal human mesothelial cells and human malignant mesothelioma cells lines in vitro. Blood 1989; 74: 9406.
  • 112
    Jonjic N, Peri G, Bernasconi S et al. Expression of adhesion molecules and chemotactic cytokines in cultured human mesothelial cells. J. Exp. Med. 1992; 176: 1165 74.
  • 113
    Topley N, Jorres A, Luttmann W et al. Human peritoneal mesothelial cells synthesize interleukin-6. Induction by IL-1 beta and TNF alpha. Kidney Int. 1993; 43: 22633.
  • 114
    Lidor YJ, Xu FJ, Martinez-Maza O et al. Constitutive production of macrophage colony-stimulating factor and interleukin-6 by human ovarian surface epithelial cells. Exp. Cell Res. 1993; 207: 3329.
  • 115
    Lanfrancone L, Boraschi D, Ghiara P et al. Human peritoneal mesothelial cells produce many cytokines (granulocyte colony-stimulating factor [CSF], granulocyte– monocyte-CSF, macrophage-CSF, interleukin-1 [IL-1], and IL-6) and are activated and stimulated to grow by IL-1. Blood 1992; 80: 283542.
  • 116
    Offner FA, Obrist P, Stadlmann S et al. IL-6 secretion by human peritoneal mesothelial and ovarian cancer cells. Cytokine 1995; 7: 5427.DOI: 10.1006/cyto.1995.0073
  • 117
    Fujino S, Yokoyama A, Kohno N, Hiwada K. Interleukin 6 is an autocrine growth factor for normal human pleural mesothelial cells. Am. J. Respir. Cell Mol. Biol. 1996; 14: 50815.
  • 118
    Xing Z, Gauldie J, Cox G et al. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J. Clin. Invest. 1998; 101: 31120.
  • 119
    Lopez-Cotarelo C, Sellhaus B, Baba HA et al. Expression of heat shock proteins 72/73 in human peritoneal mesothelial cells in vivo and in vitro. Nephron 2000; 85: 14855.
  • 120
    Chen JY, Chiu JH, Chen HL, Chen TW, Yang WC, Yang AH. Human peritoneal mesothelial cells produce nitric oxide: Induction by cytokines. Perit. Dial. Int. 2000; 20: 7727.
  • 121
    Owens MW, Grisham MB. Nitric oxide synthesis by rat pleural mesothelial cells: Induction by cytokines and lipopolysaccharide. Am. J. Physiol. 1993; 265: L110 16.
  • 122
    Tracey WR, Nakane M, Kuk J et al. The nitric oxide synthase inhibitor, L-NG-monomethylarginine, reduces carrageenan-induced pleurisy in the rat. J. Pharmacol. Exp. Ther. 1995; 273: 12959.
  • 123
    Choe N, Tanaka S, Kagan E. Asbestos fibers and interleukin-1 upregulate the formation of reactive nitrogen species in rat pleural mesothelial cells. Am. J. Respir. Cell Mol. Biol. 1998; 19: 22636.
  • 124
    Kinnula VL, Everitt JI, Mangum JB, Chang LY, Crapo JD. Antioxidant defense mechanisms in cultured pleural mesothelial cells. Am. J. Respir. Cell Mol. Biol. 1992; 7: 95103.
  • 125
    Janssen YM, Marsh JP, Absher MP et al. Oxidant stress responses in human pleural mesothelial cells exposed to asbestos. Am. J. Respir. Crit. Care Med. 1994; 149: 795802.
  • 126
    Baer AN, Green FA. Cyclooxygenase activity of cultured human mesothelial cells. Prostaglandins 1993; 46: 3749.
  • 127
    Topley N, Petersen MM, Mackenzie R et al. Human peritoneal mesothelial cell prostaglandin synthesis: Induction of cyclooxygenase mRNA by peritoneal macrophage-derived cytokines. Kidney Int. 1994; 46: 9009.
  • 128
    Tatsuguchi A, Sakamoto C, Fukuda Y et al. Induction of cyclooxygenase-2 in mesothelial cells in peritonitis caused by perforated ulcers: An immunohistochemical study in humans. Aliment. Pharmacol. Ther. 2000; 14 (Suppl. 1): 5863.
  • 129
    Coene MC, Solheid C, Claeys M, Herman AG. Prostaglandin production by cultured mesothelial cells. Arch. Int. Pharmacodyn. Ther. 1981; 249: 31618.
  • 130
    Coene MC, Van Hove C, Claeys M, Herman AG. Arachidonic acid metabolism by cultured mesothelial cells. Different transformations of exogenously added and endogenously. Biochim. Biophys. Acta 1982; 710: 437 45.
  • 131
    Hott JW, Godbey SW, Antony VB. Mesothelial cell modulation of pleural repair: Thrombin stimulated mesothelial cells release prostaglandin E2. Prostaglandins Leukot. Essent. Fatty Acids 1994; 51: 329 35.
  • 132
    Stylianou E, Jenner LA, Davies M, Coles GA, Williams JD. Isolation, culture and characterization of human peritoneal mesothelial cells. Kidney Int. 1990; 37: 1563 70.
  • 133
    Light RW. Parapneumonic effusions and infections of the pleural space. In: Light RW (ed.). Pleural Diseases, 2nd edn. Lea & Febiger, Philadelphia, 1990; 12949.
  • 134
    Brauner A, Hylander B, Wretlind B. Interleukin-6 and interleukin-8 in dialysate and serum from patients on continuous ambulatory peritoneal dialysis. Am. J. Kidney Dis. 1993; 22: 4305.
  • 135
    Topley N, Liberek T, Davenport A, Li FK, Fear H, Williams JD. Activation of inflammation and leukocyte recruitment into the peritoneal cavity. Kidney Int. Suppl. 1996; 56: S1721.
  • 136
    Zeillemaker AM, Mul FP, Hoynck van Papendrecht AA et al. Polarized secretion of interleukin-8 by human mesothelial cells: A role in neutrophil migration. Immunology 1995; 84: 22732.
  • 137
    Cannistra SA, Ottensmeier C, Tidy J, DeFranzo B. Vascular cell adhesion molecule-1 expressed by peritoneal mesothelium partly mediates the binding of activated human T lymphocytes. Exp. Hematol. 1994; 22: 996 1002.
  • 138
    Liberek T, Topley N, Luttmann W, Williams JD. Adherence of neutrophils to human peritoneal mesothelial cells: Role of intercellular adhesion molecule-1. J. Am. Soc. Nephrol. 1996; 7: 20817.
  • 139
    Zeillemaker AM, Mul FP, Hoynck van Papendrecht AA, Leguit P, Verbrugh HA, Roos D. Neutrophil adherence to and migration across monolayers of human peritoneal mesothelial cells. The role of mesothelium in the influx of neutrophils during peritonitis. J. Lab. Clin. Med. 1996; 127: 27986.
  • 140
    Van Rossen ME, Hofland LJ, Van Den Tol MP et al. Effect of inflammatory cytokines and growth factors on tumour cell adhesion to the peritoneum. J. Pathol. 2001; 193: 5307.DOI: 10.1002/1096-9896(2000)9999:9999<::aid-path805>;2-o
  • 141
    Hausmann MJ, Rogachev B, Weiler M, Chaimovitz C, Douvdevani A. Accessory role of human peritoneal mesothelial cells in antigen presentation and T-cell growth. Kidney Int. 2000; 57: 47686.DOI: 10.1046/j.1523-1755.2000.00867.x
  • 142
    Liang Y, Sasaki K. Expression of adhesion molecules relevant to leukocyte migration on the microvilli of liver peritoneal mesothelial cells. Anat. Rec. 2000; 258: 3946.DOI: 10.1002/(sici)1097-0185(20000101)258:1<39::aid-ar5>;2-#
  • 143
    Bellingan GJ, Caldwell H, Howie SE, Dransfield I, Haslett C. In vivo fate of the inflammatory macrophage during the resolution of inflammation: Inflammatory macrophages do not die locally, but emigrate to the draining lymph nodes. J. Immunol. 1996; 157: 2577 85.
  • 144
    Van Furth R. Development and distribution of mononuclear phagocytes. In: Gallin JI, Goldstein IM, Snyderman R (eds). Inflammation. Basic Principles and Clinical Correlates, 2nd edn. Raven Press, New York, 1992; 32539.
  • 145
    Martin P, Hopkinson-Woolley J, McCluskey J. Growth factors and cutaneous wound repair. Prog. Growth Factor Res. 1992; 4: 2544.
  • 146
    Mutsaers SE, Bishop JE, McGrouther G, Laurent GJ. Mechanisms of tissue repair: From wound healing to fibrosis. Int. J. Biochem. Cell Biol. 1997; 29: 517.
  • 147
    Offner FA, Feichtinger H, Stadlmann S et al. Transforming growth factor-beta synthesis by human peritoneal mesothelial cells. Induction by interleukin-1. Am. J. Pathol. 1996; 148: 167988.
  • 148
    Abendstein B, Stadlmann S, Knabbe C et al. Regulation of transforming growth factor-beta secretion by human peritoneal mesothelial and ovarian carcinoma cells. Cytokine 2000; 12: 111519.DOI: 10.1006/cyto.1999.0632
  • 149
    Saed GM, Zhang W, Chegini N, Holmdahl L, Diamond MP. Transforming growth factor beta isoforms production by human peritoneal mesothelial cells after exposure to hypoxia. Am. J. Reprod. Immunol. 2000; 43: 28591.
  • 150
    Bermudez E, Everitt J, Walker C. Expression of growth factor and growth factor receptor RNA in rat pleural mesothelial cells in culture. Exp. Cell Res. 1990; 190: 918.
  • 151
    Coker RK, Laurent GJ, Shahzeidi S et al. Transforming growth factors-beta 1, -beta 2, and -beta 3 stimulate fibroblast procollagen production in vitro but are differentially expressed during bleomycin-induced lung fibrosis. Am. J. Pathol. 1997; 150: 98191.
  • 152
    Versnel MA, Hagemeijer A, Bouts MJ, Van Der Kwast TH, Hoogsteden HC. Expression of c-sis (PDGF B-chain) and PDGF A-chain genes in ten human malignant mesothelioma cell lines derived from primary and metastatic tumors. Oncogene 1988; 2: 6015.
  • 153
    Langerak AW, Vietsch H, Bouts MJ, Hagemeijer A, Versnel MA. A spontaneously in vitro transformed mesothelial cell line has a similar pattern of PDGF chain and PDGF receptor expression to malignant mesothelioma cell lines. Eur. Respir. Rev. 1993; 3: 170 4.
  • 154
    Bird SD, Hasan Q, Davis PF, Walker RJ. Platelet derived growth factor-BB induced calcium transients in cultured human peritoneal mesothelial cells. Asaio J. 1998; 44: 83540.
  • 155
    Garlepp MJ, Christmas TI, Mutsaers SE, Manning LS, Davis MR, Robinson BWS. Platelet derived growth factor as an autocrine factor in murine malignant mesothelioma. Eur. Respir. Rev. 1993; 3: 1924.
  • 156
    Jayne DG, Perry SL, Morrison E, Farmery SM, Guillou PJ. Activated mesothelial cells produce heparin-binding growth factors: Implications for tumour metastases. Br. J. Cancer 2000; 82: 12338.
  • 157
    Faull RJ, Stanley JM, Fraser S, Power DA, Leavesley DI. HB-EGF is produced in the peritoneal cavity and enhances mesothelial cell adhesion and migration. Kidney Int. 2001; 59: 61424.
  • 158
    Lee YCG, Melkerneker D, Thompson PJ, Light RW, Lane KB. Transforming growth factor beta induces vascular endothelial growth factor elaboration from pleural mesothelial cells in vivo and in vitro. Am. J. Respir. Crit. Care Med. 2001; 165: 8894.
  • 159
    Cronauer MV, Stadlmann S, Klocker H et al. Basic fibroblast growth factor synthesis by human peritoneal mesothelial cells: Induction by interleukin-1. Am. J. Pathol. 1999; 155: 197784.
  • 160
    Kimura I, Sakamoto Y, Shibasaki M, Kobayashi Y, Matsuo H. Release of endothelins and platelet-activating factor by a rat pleural mesothelial cell line. Eur. Respir. J. 2000; 15: 1706.DOI: 10.1034/j.1399-3003.2000.15a31.x
  • 161
    Adamson IY, Bakowska J, Prieditis H. Proliferation of rat pleural mesothelial cells in response to hepatocyte and keratinocyte growth factors. Am. J. Respir. Cell Mol. Biol. 2000; 23: 3459.
  • 162
    Warn R, Harvey P, Warn A et al. HGF/SF induces mesothelial cell migration and proliferation by autocrine and paracrine pathways. Exp. Cell Res. 2001; 267: 25866.
  • 163
    Gabrielson EW, Gerwin BI, Harris CC, Roberts AB, Sporn MB, Lechner JF. Stimulation of DNA synthesis in cultured primary human mesothelial cells by specific growth factors. FASEB J. 1988; 2: 271721.
  • 164
    Gerwin BI, Lechner JF, Reddel RR et al. Comparison of production of transforming growth factor-beta and platelet-derived growth factor by normal human mesothelial cells and mesothelioma cell lines. Cancer Res. 1987; 47: 61804.
  • 165
    Laveck MA, Somers AN, Moore LL, Gerwin BI, Lechner JF. Dissimilar peptide growth factors can induce normal human mesothelial cell multiplication. In Vitro Cell Dev Biol. 1988; 24: 107784.
  • 166
    Lechner JF, LaVeck MA, Gerwin BI, Matis EA. Differential responses to growth factors by normal human mesothelial cultures from individual donors. J. Cell Physiol. 1989; 139: 295300.
  • 167
    Mutsaers SE, McAnulty RJ, Laurent GJ, Versnel MA, Whitaker D, Papadimitriou JM. Cytokine regulation of mesothelial cell proliferation in vitro and in vivo. Eur. J. Cell Biol. 1997; 72: 249.
  • 168
    Hott JW, Sparks JA, Godbey SW, Antony VB. Mesothelial cell response to pleural injury: Thrombin-induced proliferation and chemotaxis of rat pleural mesothelial cells. Am. J. Respir. Cell Mol. Biol. 1992; 6: 4215.
  • 169
    Griffith DE, Johnson AR, Kumar A, Holiday DB, Idell S. Growth factors for human pleural mesothelial cells in soluble products from formed clots. Thromb. Res. 1994; 74: 20718.
  • 170
    Rennard SI, Jaurand MC, Bignon J et al. Role of pleural mesothelial cells in the production of the submesothelial connective tissue matrix of lung. Am. Rev. Respir. Dis. 1984; 130: 26774.
  • 171
    Laurent P, Magne L, De Palmas J, Bignon J, Jaurand MC. Quantitation of elastin in human urine and rat pleural mesothelial cell matrix by a sensitive avidin–biotin ELISA for desmosine. J. Immunol. Methods 1988; 107: 111.
  • 172
    Kuwahara M, Bijwaard KE, Gersten DM, Diglio CA, Kagan E. Mesothelial cells produce a chemoattractant for lung fibroblasts: Role of fibronectin. Am. J. Respir. Cell Mol. Biol. 1991; 5: 25664.
  • 173
    Owens MW, Grimes SR. Pleural mesothelial cell response to inflammation: Tumor necrosis factor-induced mitogenesis and collagen synthesis. Am. J. Physiol. 1993; 265: L3828.
  • 174
    Owens MW, Milligan SA. Growth factor modulation of rat pleural mesothelial cell mitogenesis and collagen synthesis. Effects of epidermal growth factor and platelet-derived factor. Inflammation 1994; 18: 77 87.
  • 175
    Owens MW, Milligan SA, Grisham MB. Inhibition of pleural mesothelial cell collagen synthesis by nitric oxide. Free Radic. Biol. Med. 1996; 21: 6017.
  • 176
    Kuwahara M, Verma K, Ando T, Hemenway DR, Kagan E. Asbestos exposure stimulates pleural mesothelial cells to secrete the fibroblast chemoattractant, fibronectin. Am. J. Respir. Cell Mol. Biol. 1994; 10: 16776.
  • 177
    Harvey W, Amlot PL. Collagen production by human mesothelial cells in vitro. J. Pathol. 1983; 139: 337 47.
  • 178
    Saed GM, Zhang W, Chegini N, Holmdahl L, Diamond MP. Alteration of type I and III collagen expression in human peritoneal mesothelial cells in response to hypoxia and transforming growth factor-beta1. Wound Repair Regen. 1999; 7: 50410.
  • 179
    Yang WS, Kim BS, Lee SK, Park JS, Kim SB. Interleukin-1beta stimulates the production of extracellular matrix in cultured human peritoneal mesothelial cells. Perit. Dial. Int. 1999; 19: 21120.
  • 180
    Perfumo F, Altieri P, Degl’Innocenti ML et al. Effects of peritoneal effluents on mesothelial cells in culture: Cell proliferation and extracellular matrix regulation. Nephrol. Dial. Transplant. 1996; 11: 18039.
  • 181
    Yung S, Thomas GJ, Stylianou E, Williams JD, Coles GA, Davies M. Source of peritoneal proteoglycans. Human peritoneal mesothelial cells synthesize and secrete mainly small dermatan sulfate proteoglycans. Am. J. Pathol. 1995; 146: 5209.
  • 182
    Marshall BC, Santana A, Xu QP et al. Metalloproteinases and tissue inhibitor of metalloproteinases in mesothelial cells. Cellular differentiation influences expression. J. Clin. Invest. 1993; 91: 17929.
  • 183
    Rougier JP, Moullier P, Piedagnel R, Ronco PM. Hyperosmolality suppresses but TGF beta 1 increases MMP9 in human peritoneal mesothelial cells. Kidney Int. 1997; 51: 33747.
  • 184
    Ma C, Tarnuzzer RW, Chegini N. Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in mesothelial cells and their regulation by transforming growth factor-beta1. Wound Repair Regen. 1999; 7: 47785.
  • 185
    Howe A, Aplin AE, Alahari SK, Juliano RL. Integrin signaling and cell growth control. Curr. Opin. Cell Biol. 1998; 10: 22031.
  • 186
    Newham P, Humphries MJ. Integrin adhesion receptors: Structure, function and implications for biomedicine. Mol. Med. Today 1996; 2: 30413.
  • 187
    Liaw YS, Yu CJ, Shun CT et al. Expression of integrins in human cultured mesothelial cells: The roles in cell-to-extracellular matrix adhesion and inhibition by RGD-containing peptide. Respir. Med. 2001; 95: 221 6.
  • 188
    Leavesley DI, Stanley JM, Faull RJ. Epidermal growth factor modifies the expression and function of extracellular matrix adhesion receptors expressed by peritoneal mesothelial cells from patients on CAPD. Nephrol. Dial. Transplant. 1999; 14: 120816.
  • 189
    Boylan AM, Sanan DA, Sheppard D, Broaddus VC. Vitronectin enhances internalization of crocidolite asbestos by rabbit pleural mesothelial cells via the integrin alpha v beta 5. J. Clin. Invest. 1995; 96: 1987 2001.
  • 190
    Yen CJ, Fang CC, Chen YM et al. Extracellular matrix proteins modulate human peritoneal mesothelial cell behavior. Nephron 1997; 75: 18895.
  • 191
    Sprent J. Antigen-presenting cells. Professionals and amateurs. Curr. Biol. 1995; 5: 10957.
  • 192
    Nickoloff BJ, Turka LA. Immunological functions of non-professional antigen-presenting cells: New insights from studies of T-cell interactions with keratinocytes. Immunol. Today 1994; 15: 4649.
  • 193
    Valle MT, Degl’Innocenti ML, Bertelli R et al. Antigen-presenting function of human peritoneum mesothelial cells. Clin. Exp. Immunol. 1995; 101: 1726.
  • 194
    Cosman D, Kumaki S, Anderson D, Kennedy M, Eisenman J, Park L. Interleukin 15. Biochem. Soc. Trans. 1997; 25: 3714.
  • 195
    Kumaki S, Armitage R, Ahdieh M, Park L, Cosman D. Interleukin-15 up-regulates interleukin-2 receptor alpha chain but down-regulates its own high-affinity binding sites on human T and B cells. Eur. J. Immunol. 1996; 26: 12359.
  • 196
    Dasgupta MK, Larabie M, Halloran PF. Interferon-gamma levels in peritoneal dialysis effluents: Relation to peritonitis. Kidney Int. 1994; 46: 47581.
  • 197
    Cunliffe WJ, Sugarbaker PH. Gastrointestinal malignancy: Rationale for adjuvant therapy using early postoperative intraperitoneal chemotherapy. Br. J. Surg. 1989; 76: 108290.
  • 198
    Van Der Wal BC, Hofland LJ, Marquet RL, Van Koetsveld PM, Van Rossen ME, Van Eijck CH. Paracrine interactions between mesothelial and colon-carcinoma cells in a rat model. Int. J. Cancer 1997; 73: 88590.DOI: 10.1002/(sici)1097-0215(19971210)73:6<885::aid-ijc21>;2-2
  • 199
    Sugarbaker PH. A perspective on clinical research strategies in carcinoma of the large bowel. World J. Surg. 1991; 15: 60916.
  • 200
    Van Den Tol PM, Van Rossen EE, Van Eijck CH, Bonthuis F, Marquet RL, Jeekel H. Reduction of peritoneal trauma by using nonsurgical gauze leads to less implantation metastasis of spilled tumor cells. Ann. Surg. 1998; 227: 2428.DOI: 10.1097/00000658-199802000-00014
  • 201
    Bouvy ND, Marquet RL, Jeekel J, Bonjer HJ. Laparoscopic surgery is associated with less tumour growth stimulation than conventional surgery: An experimental study. Br. J. Surg. 1997; 84: 35861.
  • 202
    Hofer SO, Shrayer D, Reichner JS, Hoekstra HJ, Wanebo HJ. Wound-induced tumor progression: A probable role in recurrence after tumor resection. Arch. Surg. 1998; 133: 3839.
  • 203
    Cannistra SA, Kansas GS, Niloff J, DeFranzo B, Kim Y, Ottensmeier C. Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44H. Cancer Res. 1993; 53: 38308.
  • 204
    Catterall JB, Gardner MJ, Jones LM, Turner GA. Binding of ovarian cancer cells to immobilized hyaluronic acid. Glycoconj J. 1997; 14: 6479.
  • 205
    Catterall JB, Jones LM, Turner GA. Membrane protein glycosylation and CD44 content in the adhesion of human ovarian cancer cells to hyaluronan. Clin. Exp. Metastasis 1999; 17: 58391.
  • 206
    Schlaeppi M, Ruegg C, Tran-Thang C et al. Role of integrins and evidence for two distinct mechanisms mediating human colorectal carcinoma cell interaction with peritoneal mesothelial cells and extracellular matrix. Cell Adhes. Commun. 1997; 4: 43955.
  • 207
    Lessan K, Aguiar DJ, Oegema T, Siebenson L, Skubitz AP. CD44 and beta1 integrin mediate ovarian carcinoma cell adhesion to peritoneal mesothelial cells. Am. J. Pathol. 1999; 154: 152537.
  • 208
    Harada N, Mizoi T, Kinouchi M et al. Introduction of antisense CD44S CDNA down-regulates expression of overall CD44 isoforms and inhibits tumor growth and metastasis in highly metastatic colon carcinoma cells. Int. J. Cancer 2001; 91: 6775.
  • 209
    Zeng C, Toole BP, Kinney SD, Kuo JW, Stamenkovic I. Inhibition of tumor growth in vivo by hyaluronan oligomers. Int. J. Cancer 1998; 77: 396401.
  • 210
    Yashiro M, Chung YS, Inoue T et al. Hepatocyte growth factor (HGF) produced by peritoneal fibroblasts may affect mesothelial cell morphology and promote peritoneal dissemination. Int. J. Cancer 1996; 67: 289 93.
  • 211
    Nishimura S, Hirakawa-Chung KY, Yashiro M et al. TGF-beta1 produced by gastric cancer cells affects mesothelial cell morphology in peritoneal dissemination. Int. J. Oncol. 1998; 12: 84751.
  • 212
    Menzies D, Ellis H. Intestinal obstruction from adhesions: How big is the problem? Ann. R. Coll. Surg. Engl. 1990; 72: 603.
  • 213
    Ivarsson ML, Holmdahl L, Franzen G, Risberg B. Cost of bowel obstruction resulting from adhesions. Eur. J. Surg. 1997; 163: 67984.
  • 214
    Soules MR, Dennis L, Bosarge A, Moore DE. The prevention of postoperative pelvic adhesions: An animal study comparing barrier methods with dextran 70. Am. J. Obstet. Gynecol. 1982; 143: 82934.
  • 215
    Keltz MD, Peck L, Liu S, Kim AH, Arici A, Olive DL. Large bowel-to-pelvic sidewall adhesions associated with chronic pelvic pain. J. Am. Assoc. Gynecol. Laparosc. 1995; 3: 559.
  • 216
    Sulaiman H, Gabella G, Davis C et al. Growth of nerve fibres into murine peritoneal adhesions. J. Pathol. 2000; 192: 396403.DOI: 10.1002/1096-9896(2000)9999:9999<::aid-path710>;2-4
  • 217
    Sulaiman H, Gabella G, Davis MC et al. Presence and distribution of sensory nerve fibers in human peritoneal adhesions. Ann. Surg. 2001; 234: 25661.DOI: 10.1097/00000658-200108000-00016
  • 218
    Bailey LL, Ze-jian L, Schulz E, Roost H, Yahiku P. A cause of right ventricular dysfunction after cardiac operations. J. Thorac. Cardiovasc. Surg. 1984; 87: 53942.
  • 219
    Shapira N, Gordon CI, Lemole GM. Occlusion of aortocoronary vein grafts in association with bovine pericardium. Am. J. Cardiovasc. Pathol. 1990; 3: 87 90.
  • 220
    Morrissey JH, Gregory SA, Mackman N, Edgington TS. Tissue factor regulation and gene organization. Oxf. Surv. Eukaryot. Genes 1989; 6: 6784.
  • 221
    Idell S, Zwieb C, Kumar A, Koenig KB, Johnson AR. Pathways of fibrin turnover of human pleural mesothelial cells in vitro. Am. J. Respir. Cell Mol. Biol. 1992; 7: 41426.
  • 222
    Kumar A, Koenig KB, Johnson AR, Idell S. Expression and assembly of procoagulant complexes by human pleural mesothelial cells. Thromb. Haemost. 1994; 71: 58792.
  • 223
    Bottles KD, Laszik Z, Morrissey JH, Kinasewitz GT. Tissue factor expression in mesothelial cells: Induction both in vivo and in vitro. Am. J. Respir. Cell Mol. Biol. 1997; 17: 16472.
  • 224
    Whawell SA, Vipond MN, Scott-Coombes DM, Thompson JN. Plasminogen activator inhibitor 2 reduces peritoneal fibrinolytic activity in inflammation. Br. J. Surg. 1993; 80: 1079.
  • 225
    Whawell SA, Thompson EM, Fleming KA, Thompson JN. Plasminogen activator inhibitor-2 expression in inflamed appendix. Histopathology 1995; 27: 758.
  • 226
    Van Hinsbergh VW, Kooistra T, Scheffer MA, Hajo van Bockel J, Van Muijen GN. Characterization and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells. Blood 1990; 75: 14907.
  • 227
    Rougier JP, Guia S, Hagege J, Nguyen G, Ronco PM. PAI-1 secretion and matrix deposition in human peritoneal mesothelial cell cultures: Transcriptional regulation by TGF-beta 1. Kidney Int. 1998; 54: 8798.
  • 228
    Ivarsson ML, Holmdahl L, Falk P, Molne J, Risberg B. Characterization and fibrinolytic properties of mesothelial cells isolated from peritoneal lavage. Scand. J. Clin. Lab. Invest. 1998; 58: 195203.
  • 229
    Plow EF, Herren T, Redlitz A, Miles LA, Hoover-Plow JL. The cell biology of the plasminogen system. FASEB J. 1995; 9: 93945.
  • 230
    Sitter T, Spannagl M, Schiffl H, Held E, Van Hinsbergh VW, Kooistra T. Imbalance between intraperitoneal coagulation and fibrinolysis during peritonitis of CAPD patients: The role of mesothelial cells. Nephrol. Dial. Transplant. 1995; 10: 67783.
  • 231
    Holmdahl L, Eriksson E, Eriksson BI, Risberg B. Depression of peritoneal fibrinolysis during operation is a local response to trauma. Surgery 1998; 123: 539 44.
  • 232
    Sitter T, Toet K, Fricke H, Schiffl H, Held E, Kooistra T. Modulation of procoagulant and fibrinolytic system components of mesothelial cells by inflammatory mediators. Am. J. Physiol. 1996; 271: R125663.
  • 233
    Sitter T, Toet K, Quax P, Kooistra T. Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue-type plasminogen activator. Kidney Int. 1999; 55: 1209.
  • 234
    Tietze L, Elbrecht A, Schauerte C et al. Modulation of pro- and antifibrinolytic properties of human peritoneal mesothelial cells by transforming growth factor beta1 (TGF-beta1), tumor necrosis factor alpha (TNF-alpha) and interleukin 1beta (IL-1beta). Thromb. Haemost. 1998; 79: 36270.
  • 235
    Whawell SA, Thompson JN. Cytokine-induced release of plasminogen activator inhibitor-1 by human mesothelial cells. Eur. J. Surg. 1995; 161: 31518.
  • 236
    Falk P, Ma C, Chegini N, Holmdahl L. Differential regulation of mesothelial cell fibrinolysis by transforming growth factor beta 1. Scand. J. Clin. Lab. Invest. 2000; 60: 43947.
  • 237
    Mandl-Weber S, Haslinger B, Sitter T. Thrombin upregulates production of plasminogen activator inhibitor type 1 in human peritoneal mesothelial cells. Perit. Dial. Int. 1999; 19: 31924.
  • 238
    Lee YC, Devin CJ, Teixeira LR et al. Transforming growth factor beta2 induced pleurodesis is not inhibited by corticosteroids. Thorax 2001; 56: 6438.
  • 239
    Lee YC, Lane KB, Parker RE et al. Transforming growth factor beta (2) (TGF beta (2)) produces effective pleurodesis in sheep with no systemic complications. Thorax 2000; 55: 105862.
  • 240
    Falk K, Bjorquist P, Stromqvist M, Holmdahl L. Reduction of experimental adhesion formation by inhibition of plasminogen activator inhibitor type 1. Br. J. Surg. 2001; 88: 2869.
  • 241
    Lucas PA, Warejcka DJ, Young HE, Lee BY. Formation of abdominal adhesions is inhibited by antibodies to transforming growth factor-beta1. J. Surg. Res. 1996; 65: 1358.
  • 242
    Farquhar C, Vandekerckhove P, Watson A, Vail A, Wiseman D. Barrier agents for preventing adhesions after surgery for subfertility. Cochrane Database Syst. Rev. 2000; 2: CD000475.
  • 243
    Hertzler AE(ed.). The Peritoneum. Mosby Company, St Louis, 1919.
  • 244
    Raftery AT. Regeneration of parietal and visceral peritoneum: An electron microscopical study. J. Anat. 1973; 115: 37592.
  • 245
    Raftery AT. Regeneration of parietal and visceral peritoneum in the immature animal: A light and electron microscopical study. Br. J. Surg. 1973; 60: 96975.
  • 246
    Teranishi S, Sakaguchi M, Itaya H. Mesothelial regeneration in the rat and effect of urokinase. Nippon Geka Hokan 1977; 46: 36179.
  • 247
    Cameron GR, Hassan SM, De SN. Repair of Glisson's capsule after tangential wounds of the liver. J. Pathol. Bacteriol. 1957; 73: 110.
  • 248
    Ryan GB, Grobety J, Majno G. Mesothelial injury and recovery. Am. J. Pathol. 1973; 71: 93112.
  • 249
    Wheeldon EB, Mariassy AT, McSporran KD. The pleura: A combined light microscopic and scanning and transmission electron microscopic study in the sheep. II. Response to injury. Exp. Lung Res. 1983; 5: 12540.
  • 250
    Mutsaers SE, Whitaker D, Papadimitriou JM. Mesothelial regeneration is not dependent on subserosal cells. J. Pathol. 2000; 190: 8692.DOI: 10.1002/(sici)1096-9896(200001)190:1<86::aid-path493>;2-g
  • 251
    Waters CM, Chang JY, Glucksberg MR, DePaola N, Grotberg JB. Mechanical forces alter growth factor release by pleural mesothelial cells. Am. J. Physiol. 1997; 272: L5527.
  • 252
    Ellis H, Harrison W, Tugh TB. The healing of peritoneum under normal and pathological conditions. Br. J. Surg. 1965; 52: 4716.
  • 253
    Davila RM, Crouch EC. Role of mesothelial and submesothelial stromal cells in matrix remodeling following pleural injury. Am. J. Pathol. 1993; 142: 54755.
  • 254
    Bolen JW, Hammar SP, McNutt MA. Reactive and neoplastic serosal tissue. A light-microscopic, ultrastructural, and immunocytochemical study. Am. J. Surg. Pathol. 1986; 10: 3447.
  • 255
    Bolen JW, Hammar SP, McNutt MA. Serosal tissue: Reactive tissue as a model for understanding mesotheliomas. Ultrastruct. Pathol. 1987; 11: 25162.
  • 256
    Whitaker D, Manning LS, Robinson BWS, Shilkin KB. The pathobiology of the mesothelium. In: Henderson DW, Shilkin KB, Langlois SLeP, Whitaker D (eds). Malignant Mesothelioma. Hemisphere Publishing, New York, 1992; 2568.
  • 257
    Johnson FR, Whitting HW. Repair of parietal peritoneum. Br. J. Surg. 1962; 49: 65360.
  • 258
    Eskeland G, Kjaerheim A. Growth of autologous peritoneal fluid cells in intraperitoneal diffusion chambers in rats. II. An electron microscopical study. Acta Pathol. Microbiol. Scand. 1966; 68: 50116.
  • 259
    Venables C, Ellis H, Burns JE. The effects of X-radiation on peritoneal healing: An experimental study. Br. J. Radiol. 1967; 40: 2759.
  • 260
    Watters WB, Buck RC. Mitotic activity of peritoneum in contact with a regenerating area of peritoneum. Virchows Arch. B Cell Pathol. 1973; 13: 4854.
  • 261
    Cleaver CL, Hopkins AD, Ng Nee Kwong KC, Raftery AT. The effect of postoperative peritoneal lavage on survival, peritoneal wound healing and adhesion formation following fecal peritonitis: An experimental study in the rat. Br. J. Surg. 1974; 61: 6014.
  • 262
    Rampino T, Cancarini G, Gregorini M et al. Hepatocyte growth factor/scatter factor released during peritonitis is active on mesothelial cells. Am. J. Pathol. 2001; 159: 127585.
  • 263
    Davidson B, Nielsen S, Christensen J et al. The role of desmin and N-cadherin in effusion cytology: A comparative study using established markers of mesothelial and epithelial cells. Am. J. Surg. Pathol. 2001; 25: 140512.DOI: 10.1097/00000478-200111000-00008
  • 264
    Simsir A, Fetsch P, Mehta D, Zakowski M, Abati A. E-Cadherin, N-cadherin, and calretinin in pleural effusions: The good, the bad, the worthless. Diagn. Cytopathol. 1999; 20: 12530.DOI: 10.1002/(sici)1097-0339(199903)20:3<125::aid-dc3>;2-v
  • 265
    Perkins RC, Broaddus VC, Shetty S, Hamilton S, Idell S. Asbestos upregulates expression of the urokinase-type plasminogen activator receptor on mesothelial cells. Am. J. Respir. Cell Mol. Biol. 1999; 21: 63746.